Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 15 clinical trials
Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with

lipodystrophy
haart
raltegravir
  • 34 views
  • 08 Nov, 2020
  • 1 location
Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment

Subjects with HIV who have viral suppression on current regimen but also have side effects/intolerance will change their current regimen to a combination of Raltegravir and Atazanavir and

antiviral drugs
hiv viral load
hysterectomy
raltegravir
antiretroviral agents
  • 8 views
  • 07 Nov, 2020
  • 1 location
Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients

Phase 4, single arm, open label study designed to compare the safety and efficacy of antiviral activity and immunological effect of Maraviroc in combination with Raltegravir and Darunavir

antiviral
elisa
maraviroc
darunavir
reverse transcriptase inhibitor
  • 24 views
  • 08 Nov, 2020
  • 1 location
Combination Antiretroviral Therapy (cART) for PBC

Placebo Controlled, double-blind randomized controlled trial (RCT) with 12 months Tenofovir Disoproxil and Raltegravir for primary biliary cholangitis (PBC) patients unresponsive to

  • 0 views
  • 28 Jan, 2021
  • 5 locations
Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among HIV-infected infants.

hiv antibody
enzyme-linked immunosorbent assay
lopinavir
antiretroviral therapy
hiv antibodies
  • 94 views
  • 24 Jan, 2021
  • 49 locations
Pharmacokinetics Distribution of Raltegravir by PET/MR

This is a single-center drug distribution and pharmacokinetic study of a single microdose of 18F-raltegravir given to 10 HIV-infected subjects who are either taking or not taking a raltegravir

  • 14 views
  • 30 Mar, 2021
  • 1 location
Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

The study will investigate whether combination antiretroviral therapy of raltegravir and 3TC/ABC is effective and safe to use in tuberculosis (TB)/HIV co-infected adults receiving

abacavir
mycobacterial infection
mycobacterium tuberculosis
lamivudine
hiv-1 rna measurement
  • 6 views
  • 08 Nov, 2020
  • 1 location
Effects of Raltegravir (Isentress ) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy Volunteers

Raltegravir is the first of a new antiretroviral class. A better profile of metabolic toxicity is expected. In order to better define its effects, without interference with other drugs, a

hepatitis b
blood test
drugs of abuse
  • 53 views
  • 07 Nov, 2020
  • 1 location
HIV-1 Infected Patients Phase II Trial Dual Combination Doravirine/Raltegravir Open Label

/raltegravir (immediate switch group) or to the maintaining of their current ART followed by a switch to doravirine/raltegravir at W48 (delayed switch group). Patients will be followed during 96 weeks.

  • 0 views
  • 12 Feb, 2021
  • 1 location
A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

This is a pilot randomized controlled Open-label trial to compare raltegravir and nevirapine as anchor Drug in combined antiretroviral therapy(ART) for ART-naive HIV+ Chinese injection

hiv-1 infection
antiretroviral therapy
opportunistic infection
nevirapine
western blot
  • 6 views
  • 08 Nov, 2020
  • 1 location